Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wambui, Machua"'
Publikováno v:
American Journal of Case Reports. 23
BACKGROUND Systemic lupus erythematosus (SLE) is an autoimmune disorder affecting multiple organ systems with a wide spectrum of clinical presentation and associated with positive serologies. Musculoskeletal involvement in patients with SLE is relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d31d1c634ad9cf253ea844b1990c59
https://doi.org/10.12659/ajcr.932867
https://doi.org/10.12659/ajcr.932867
Autor:
Fotios Koumpouras, Anca D. Askanase, Paul J. Foster, Joshua June, Judith A. James, Arezou Khosroshahi, Joan T. Merrill, Saira Z Sheikh, Wambui Machua, Joel M. Guthridge, Gaurav Rathi, Debra Zack, Mohammad Faisal Khan, Bart Burington
Publikováno v:
Poster Presentations.
Background: XmAb5871 is a humanized anti-CD19 antibody Fc-engineered for increased affinity to FcγRIIb. Co-ligation of CD19 and FcγRIIb inhibits B lineage cells key to SLE pathogenesis. Objectives: This Phase 2 study was designed to minimize backgr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69b26fd9d69dc48e4ca901607a69c1be
https://doi.org/10.1136/annrheumdis-2019-eular.4234
https://doi.org/10.1136/annrheumdis-2019-eular.4234
Autor:
Debra Zack, Fotios Koumpouras, Mohammed Faisal Khan, Arezou Khosroshahi, Joan T. Merrill, Wambui Machua, Joshua June, Paul J. Foster, Saira Z Sheikh, Anca Askanase
Publikováno v:
Abstracts.
Background XmAb5871 is a humanized anti-CD19 antibody Fc-engineered for increased affinity to FcgammaRIIb. Co-ligation of CD19 and FcgammaRIIb inhibits B lineage cells key to lupus pathogenesis. This Phase 2 study in SLE was designed to minimize back
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a81ea58c3c669d2018716d2f4f582c7
https://doi.org/10.1136/lupus-2019-lsm.98
https://doi.org/10.1136/lupus-2019-lsm.98
Autor:
Monique Bethel, Wambui Machua, Frances M. Yang, N Stanley Nahman, Laura D Carbone, Alyce M Oliver, Shuang Li
Publikováno v:
Journal of Investigative Medicine. 64:908-910
Objectives To determine dosing patterns and examine predictors of filled hydroxychloroquine (HCQ) prescriptions in patients with systemic lupus erythematosus (SLE) with end-stage renal disease (ESRD). Methods This was a retrospective cohort study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f963e753cdbf55b74ad7e2b28d9f4f7
https://doi.org/10.1136/jim-2016-000065
https://doi.org/10.1136/jim-2016-000065
Autor:
Wambui Machua, Alyce M. Oliver
Publikováno v:
JCR: Journal of Clinical Rheumatology. 22:47-48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b6fb8e38b1c78d092527a2739d33bc2
https://doi.org/10.1097/rhu.0000000000000342
https://doi.org/10.1097/rhu.0000000000000342